Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| QBDSX | 8.03 | 0.01 | +0.12% |
| Quantified Managed Income Investor | |||
| RPMYX | 11.22 | -0.08 | -0.71% |
| Reinhart International PMV Advisor | |||
| AWAYX | 21.61 | -0.35 | -1.59% |
| AB Wealth Appreciation Strategy Advisor | |||
| FASEX | 55.26 | -1.03 | -1.83% |
| Nuveen Mid Cap Value 1 A | |||
| MEFYX | 17.64 | -0.46 | -2.54% |
| MassMutual Mid Cap Growth Svc | |||
A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.
| Ticker / NAME | Correlation To EAPIF | 1D Price Change % | ||
|---|---|---|---|---|
| EAPIF | 100% | N/A | ||
| HLN - EAPIF | 14% Poorly correlated | +1.82% | ||
| HLNCF - EAPIF | 11% Poorly correlated | +1.99% | ||
| DHBUF - EAPIF | 10% Poorly correlated | N/A | ||
| IXHL - EAPIF | 7% Poorly correlated | +0.32% | ||
| STEK - EAPIF | 6% Poorly correlated | +0.73% | ||
More | ||||